Literature DB >> 1913594

Inversions and tandem translocations involving chromosome 14q11 and 14q32 in T-prolymphocytic leukemia and T-cell leukemias in patients with ataxia telangiectasia.

V Brito-Babapulle1, D Catovsky.   

Abstract

Ataxia telangiectasia (AT) and T-prolymphocytic leukemia (T-PLL) have similar chromosome abnormalities. Cytogenetic findings reported in 5 patients with AT who developed T-cell leukemia revealed: inv(14)(q11q32) (1 case), tandem translocations of chromosome 14 with breakpoints at q11 and q32 (3 cases), and int. del(14)(q11q32) (1 case). Additional abnormalities were present in 4 patients of whom two had trisomy for 8q. Of 27 patients with T-PLL but without AT, investigated by us, 17 had inv(14)(q11q32) and 3 had tandem rearrangement of chromosome 14 with breaks at 14q11 and q32; 15 of them also had rearrangements resulting in trisomy 8q. Two of the leukemias supervening on AT had morphology and clinical course suggestive of T-PLL. Two other cases of AT studied by us developed typical T-PLL at a young age (18 and 39 years). T-cell clones carrying an inv(14), tandem t(14;14) and t(X;14) can be present in AT for long periods of time without evolving into leukemia. In T-PLL, inv(14) and t(14;14) always occurs with other chromosome abnormalities. We suggest that these additional chromosome abnormalities may be required for the leukemic transformation of AT. This is supported by one of the two AT cases studied by us in which a long-standing t(X;14) clone evolved with the formation of t(1;14)(p21;q11), t(8;22)(q24;q11) at the time of the development of T-PLL.

Entities:  

Mesh:

Year:  1991        PMID: 1913594     DOI: 10.1016/0165-4608(91)90228-m

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  12 in total

Review 1.  Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia.

Authors:  Philipp B Staber; Marco Herling; Mar Bellido; Eric D Jacobsen; Matthew S Davids; Tapan Mahendra Kadia; Andrei Shustov; Olivier Tournilhac; Emmanuel Bachy; Francesco Zaja; Kimmo Porkka; Gregor Hoermann; Ingrid Simonitsch-Klupp; Claudia Haferlach; Stefan Kubicek; Marius E Mayerhoefer; Georg Hopfinger; Ulrich Jaeger; Claire Dearden
Journal:  Blood       Date:  2019-07-10       Impact factor: 22.113

2.  T-cell prolymphocytic leukemia.

Authors:  Robbie L Graham; Barry Cooper; John R Krause
Journal:  Proc (Bayl Univ Med Cent)       Date:  2013-01

3.  Chromosome walking on the TCL1 locus involved in T-cell neoplasia.

Authors:  L Virgilio; M Isobe; M G Narducci; P Carotenuto; B Camerini; N Kurosawa; C M Croce; G Russo
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

4.  Identification of the TCL1 gene involved in T-cell malignancies.

Authors:  L Virgilio; M G Narducci; M Isobe; L G Billips; M D Cooper; C M Croce; G Russo
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

Review 5.  Prolymphocytic Leukemia: New Insights in Diagnosis and in Treatment.

Authors:  Aude Collignon; Anne Wanquet; Elsa Maitre; Edouard Cornet; Xavier Troussard; Thérèse Aurran-Schleinitz
Journal:  Curr Oncol Rep       Date:  2017-04       Impact factor: 5.075

Review 6.  Current status of human chromosome 14.

Authors:  D Kamnasaran; D W Cox
Journal:  J Med Genet       Date:  2002-02       Impact factor: 6.318

7.  High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia.

Authors:  Marco Herling; Kaushali A Patel; Michael A Teitell; Marina Konopleva; Farhad Ravandi; Ryuji Kobayashi; Dan Jones
Journal:  Blood       Date:  2007-09-21       Impact factor: 22.113

8.  Incidence of TCR and TCL1 gene translocations and isochromosome 7q in peripheral T-cell lymphomas using fluorescence in situ hybridization.

Authors:  Andrew L Feldman; Mark Law; Karen L Grogg; Erik C Thorland; Stephanie Fink; Paul J Kurtin; William R Macon; Ellen D Remstein; Ahmet Dogan
Journal:  Am J Clin Pathol       Date:  2008-08       Impact factor: 2.493

Review 9.  Prolymphocytic leukemia.

Authors:  Ahmed Absi; Eric Hsi; Matt Kalaycio
Journal:  Curr Treat Options Oncol       Date:  2005-05

10.  Molecular investigation of coexistent chronic myeloid leukaemia and peripheral T-cell lymphoma - a case report.

Authors:  Alicja M Gruszka; Cristina Rabascio; Laura Cannella; Simona Sammassimo; Giovanna Andreola; Giuliana Gregato; Mario Faretta; Angelica Calleri; Rita De Molfetta; Giancarlo Pruneri; Francesco Bertolini; Myriam Alcalay
Journal:  Sci Rep       Date:  2015-10-06       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.